HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Computational modelling predicts impaired barrier function and higher sensitivity to skin inflammation following pH elevation.

Abstract
Skin surface pH has been identified as a key regulator of the epidermal homeostasis through its action on serine protease activity. These enzymes, like kallikreins (KLK), are responsible for the degradation of corneodesmosomes, the protein structures linking together corneocytes, and are regulated by Lympho-Epithelial Kazal-Type-related Inhibitor (LEKTI). KLK activity increases at pH levels higher than physiological. An increase in skin surface pH has been observed in patients suffering from skin diseases characterized by impaired barrier function, like atopic dermatitis. In this work, we introduce an agent-based model of the epidermis to study the impact of a change in skin surface pH on the structural and physiological properties of the epidermis, through the LEKTI-KLK mechanism. We demonstrate that a less acidic pH, compared to the slightly acidic pH observed in healthy skin, is sufficient to significantly affect the water loss at the surface and the amount of irritant permeating through the epidermis. This weakening of the skin barrier function eventually results in a more intense skin inflammation following exposure to an external irritant. This work provides additional evidence that skin surface pH and serine proteases can be therapeutic targets to improve skin barrier integrity.
AuthorsEléa Thibault Greugny, Jalil Bensaci, François Fages, Georgios N Stamatas
JournalExperimental dermatology (Exp Dermatol) Vol. 32 Issue 2 Pg. 177-185 (02 2023) ISSN: 1600-0625 [Electronic] Denmark
PMID36321871 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 John Wiley & Sons Ltd.
Chemical References
  • Irritants
  • Kallikreins
  • Serine Peptidase Inhibitor Kazal-Type 5
Topics
  • Humans
  • Irritants
  • Epidermis (metabolism)
  • Kallikreins (metabolism)
  • Serine Peptidase Inhibitor Kazal-Type 5 (metabolism)
  • Inflammation (metabolism)
  • Hydrogen-Ion Concentration
  • Homeostasis
  • Computer Simulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: